{
    "medicine_id": "aa76112746bf3a7363c6e13ec96265fad6e438bf",
    "platform_id": "DB05485",
    "metadata": {
        "name": "Adult Formula 50 60 61 v v Solution",
        "composition": "60 61 v v ADH 1",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in breast cancer cancer tumors unspecified melanoma ovarian cancer and solid tumors",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "ADH 1 is a biotech compounds that targets N cadherin a protein present on certain tumor cells and established tumor blood vessels Cadherins are cell adhesion and cell signaling molecules crucial to the development of tissues organs and organisms Agents that target and inhibit cadherin function have the potential to attack the progression of cancer at two distinct points Direct targeting of cadherins expressed on cancer cells may disturb cadherin mediated signaling leading to apoptosis death of cancer cells Cadherin inhibitors may exploit the inherent structural weaknesses of the tumor vasculature causing angiolysis disruption of blood vessels and tumor damage The compound is indicated for treatment of a variety of invasive carcinomas and ADH 1 has been shown to be synergistic with taxane based chemotherapy in the systemic treatment of ovarian cancer xenografts",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}